Sale!

Malaria P.Falciparum RNA Detection Qualitative Test Cost

Original price was: 800 د.إ.Current price is: 680 د.إ.

-15%

The “Malaria P.Falciparum RNA Detection Qualitative Test” is a sophisticated diagnostic procedure aimed at identifying the presence of the RNA of Plasmodium falciparum, the most dangerous and prevalent parasite causing malaria in humans. This test employs advanced molecular techniques to qualitatively detect the specific RNA sequences of the parasite, ensuring a high level of accuracy in diagnosing malaria caused by P. falciparum. Conducted at DNA Labs UAE, a leading facility in medical diagnostics, the test is priced at 680 AED. It is especially crucial for early detection and timely treatment of malaria, significantly impacting patient outcomes by enabling healthcare providers to initiate appropriate interventions promptly. This test stands as a critical tool in the fight against malaria, offering a reliable method for detecting the disease in its early stages.

Description

Malaria P.Falciparum RNA Detection Qualitative Test

Test Name: Malaria P.Falciparum RNA Detection Qualitative Test

Components: Whole Blood, dried spot.

Price: 680.0 AED

Sample Condition: Whole Blood, dried spot.

Report Delivery: 3rd Working Day Email: 36 hours. On phone: 24 hours

Method: Real Time PCR

Test type: Viral

Doctor: Physician

Test Department: Genetics

Pre Test Information: Need to sign Consent document and bring any clinical history of patient for Malaria (P.Falciparum) (RNA Detection) Qualitative Test

Test Details:

The Malaria (P. falciparum) RNA detection qualitative test is a diagnostic tool used to detect the presence of RNA from the Plasmodium falciparum parasite in a patient’s blood sample. This test is typically used in areas where malaria is endemic and can help in the early detection and treatment of the disease.

The test works by extracting RNA from the patient’s blood sample and then using a technique called reverse transcription-polymerase chain reaction (RT-PCR) to amplify and detect specific RNA sequences from the P. falciparum parasite. The RT-PCR technique converts the RNA into complementary DNA (cDNA) and then amplifies it using specific primers that target the P. falciparum RNA.

If the P. falciparum RNA is present in the patient’s blood sample, the RT-PCR technique will amplify the specific RNA sequences, and the presence of the amplified DNA can be detected using various methods, such as gel electrophoresis or fluorescence-based detection systems.

A positive result from the Malaria (P. falciparum) RNA detection qualitative test indicates the presence of the P. falciparum parasite in the patient’s blood, confirming a diagnosis of malaria caused by this specific parasite. This information is crucial for the appropriate treatment and management of the disease.

It’s important to note that this test detects the presence of RNA from the P. falciparum parasite, which is one of the four main species of Plasmodium that cause malaria in humans. Other species, such as P. vivax, P. malariae, and P. ovale, may require different diagnostic tests for detection.

Overall, the Malaria (P. falciparum) RNA detection qualitative test is a valuable tool in the diagnosis and management of malaria caused by the P. falciparum parasite. It provides a rapid and accurate method for detecting the presence of this specific parasite in a patient’s blood sample, allowing for early intervention and treatment.

Test Name	Malaria P.Falciparum RNA Detection Qualitative Test
Components
Price	680.0 AED
Sample Condition	Whole Blood,dried spot.
Report Delivery	3rd Working Day Email:-36 hours.On phone: 24 hours
Method	Real Time PCR
Test type	Viral
Doctor	Physician
Test Department:	Genetics
Pre Test Information	Need to sign Consent document and bring any clinical history of patient forMalaria (P.Falciparum) (RNA Detection) QualitativeTest
Test Details	The Malaria (P. falciparum) RNA detection qualitative test is a diagnostic tool used to detect the presence of RNA from the Plasmodium falciparum parasite in a patient’s blood sample. This test is typically used in areas where malaria is endemic and can help in the early detection and treatment of the disease. The test works by extracting RNA from the patient’s blood sample and then using a technique called reverse transcription-polymerase chain reaction (RT-PCR) to amplify and detect specific RNA sequences from the P. falciparum parasite. The RT-PCR technique converts the RNA into complementary DNA (cDNA) and then amplifies it using specific primers that target the P. falciparum RNA. If the P. falciparum RNA is present in the patient’s blood sample, the RT-PCR technique will amplify the specific RNA sequences, and the presence of the amplified DNA can be detected using various methods, such as gel electrophoresis or fluorescence-based detection systems. A positive result from the Malaria (P. falciparum) RNA detection qualitative test indicates the presence of the P. falciparum parasite in the patient’s blood, confirming a diagnosis of malaria caused by this specific parasite. This information is crucial for the appropriate treatment and management of the disease. It’s important to note that this test detects the presence of RNA from the P. falciparum parasite, which is one of the four main species of Plasmodium that cause malaria in humans. Other species, such as P. vivax, P. malariae, and P. ovale, may require different diagnostic tests for detection. Overall, the Malaria (P. falciparum) RNA detection qualitative test is a valuable tool in the diagnosis and management of malaria caused by the P. falciparum parasite. It provides a rapid and accurate method for detecting the presence of this specific parasite in a patient’s blood sample, allowing for early intervention and treatment.